| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/16/2013 | CN102875567A Piperazine compound and preparation and usage thereof |
| 01/16/2013 | CN102875547A Vinpocetine compound and its preparation method |
| 01/16/2013 | CN102875518A Genipin methyl ether, preparation method and medicine application thereof |
| 01/16/2013 | CN102875479A Quinazoline diketone derivative and preparation method, drug compound and application thereof |
| 01/16/2013 | CN102875441A Plexxikon inc |
| 01/16/2013 | CN102875430A Modafinil polymorphic forms |
| 01/16/2013 | CN102875429A Modafinil polymorphic forms |
| 01/16/2013 | CN102875336A 2-substituted benzene alkynyl-1,2-dihydro-1-naphthalene alcohol compound, preparation method thereof and application of compound to preparation of acetylcholinesterase resisting medicine |
| 01/16/2013 | CN102872443A Drug for treating migraine and preparation method thereof |
| 01/16/2013 | CN102872429A Formula of traditional Chinese medicine for treating shaking palsy caused by wind phlegm fire |
| 01/16/2013 | CN102872421A Traditional Chinese medicine blood stasis dissipating mixture for treating cranial injury sequelae |
| 01/16/2013 | CN102872404A Traditional Chinese medicine for treating phlegm-dampness collateral-blocking syndrome-type tinnitus cerebri |
| 01/16/2013 | CN102872382A Achyranthes bidentata tablet for calming liver and relieveing dizziness |
| 01/16/2013 | CN102872350A Headache pain-killer |
| 01/16/2013 | CN102872348A Formula of traditional Chinese medicine for treating shaking palsy caused by qi and blood deficiency |
| 01/16/2013 | CN102872343A Nursing hydropathic compress liquid for promoting recovery of nerve injury |
| 01/16/2013 | CN102872335A Externally used Chinese medicine preparation for curing diabetic foot and preparation method thereof |
| 01/16/2013 | CN102872322A Tortoise plastron tablets for nourishing yin |
| 01/16/2013 | CN102872320A Formula of traditional Chinese medicine for treating shaking palsy caused by enterohepatic yin deficiency |
| 01/16/2013 | CN102872319A Traditional Chinese medicine extract of total saponin ingredients and preparation method of same |
| 01/16/2013 | CN102872309A Chinese medicine formulation of climacteric mind tranquilizing drug for treating climacteric syndrome and dysfunction of autonomic nervous system |
| 01/16/2013 | CN102872297A Tablets for tonifying kidney and replenishing essence |
| 01/16/2013 | CN102872292A Traditional Chinese medicine for curing spleen and kidney deficiency type ischemic post-stroke depression |
| 01/16/2013 | CN102872275A Decoction medicine for treating insomnia caused by pathogenic fire derived from stagnation of liver-QI |
| 01/16/2013 | CN102872271A Traditional Chinese medicine for treating cold |
| 01/16/2013 | CN102872254A Granules for activating blood and removing stasis |
| 01/16/2013 | CN102872249A Ventricular hemorrhage health care product containing compound Chinese medicine tincture and a preparation method for ventricular hemorrhage health care product |
| 01/16/2013 | CN102872239A Qi-tonifying and yang-raising tablets |
| 01/16/2013 | CN102872237A Skunk bugbane spleen-qi raising tablet |
| 01/16/2013 | CN102872224A Externally-applied sleeping cream |
| 01/16/2013 | CN102872214A Medicine for treating migraine and preparation method of medicine |
| 01/16/2013 | CN102872212A Screening method of liver X receptor agonist |
| 01/16/2013 | CN102872178A Preparation method of ginseng oligosaccharide extract and application of ginseng oligosaccharide extract |
| 01/16/2013 | CN102872176A Antiepileptic drug, preparation method and application thereof |
| 01/16/2013 | CN102872155A Application of flavonoid glycoside compound on medicine for treating cerebral apoplexy |
| 01/16/2013 | CN102872065A Novel application of naringin |
| 01/16/2013 | CN102872052A Application of gypensapogenin B to Alzheimer disease treatment drugs |
| 01/16/2013 | CN102872051A Application of gypensapogenin A to antidepressant drugs |
| 01/16/2013 | CN102872050A Application of gypensapogenin A to Alzheimer disease treatment drugs |
| 01/16/2013 | CN102872048A Application of gypensapogenin B to ischemic brain injury treatment drugs |
| 01/16/2013 | CN102872020A Inhibitor of pai-1 production |
| 01/16/2013 | CN102872016A Medicine combination |
| 01/16/2013 | CN102872012A Compound capable of inhibiting protein kinase and application thereof |
| 01/16/2013 | CN102872011A Pharmaceutical composition comprising (S)-4-hydroxy-2-oxo-1-pyrrolidine acetamide |
| 01/16/2013 | CN102871997A Controlled-release medicinal composition containing demethyl venlafaxine benzoate compounds |
| 01/16/2013 | CN102871993A Novel application of bitter |
| 01/16/2013 | CN102871987A Method for providing fast relief for user through nicotine chewing gum |
| 01/16/2013 | CN102871981A Tablet medicine compound containing levetiracetam |
| 01/16/2013 | CN102871979A Slow release pharmaceutical preparation and method of administering same |
| 01/16/2013 | CN102871978A Levosulpiride tablets and preparation method thereof |
| 01/16/2013 | CN102871969A Application of erythropoietin microspheres to preparation of drugs for treating motor complications in Parkinson's disease |
| 01/16/2013 | CN102871959A Stable (S)-4-hydroxy-2-oxo-1-pyrrolidine acetamide pharmaceutical composition |
| 01/16/2013 | CN102871950A 一种熊果酸固体分散体及其制备方法 One kind of ursolic acid solid dispersion and its preparation method |
| 01/16/2013 | CN102871071A Ginger powder and processing method thereof |
| 01/16/2013 | CN102327336B External sleeping patch |
| 01/16/2013 | CN102302734B Agent for treating insomnia |
| 01/16/2013 | CN102284037B Medicament for treating involutional melancholia |
| 01/16/2013 | CN102240391B Traditional Chinese medicine solution for health promotion |
| 01/16/2013 | CN102180928B 3-beta,5-alpha,6-beta-trihydroxy steroid compounds, and synthesis method and application thereof |
| 01/16/2013 | CN102154301B Preparation and application of conotoxin striatus S21a in South China Sea |
| 01/16/2013 | CN102150859B Composition with functions of relieving physical fatigue and improving memory as well as preparation method and application thereof |
| 01/16/2013 | CN102125522B P-glycoprotein monoclonal antibody modified phenytoin targeting nanopreparation and preparation method thereof |
| 01/16/2013 | CN102080085B Human miR-193b antisense nucleotide and application thereof |
| 01/16/2013 | CN101985464B High-stability PAC1 type receptor specific agonist MPAPO and preparation method and application thereof |
| 01/16/2013 | CN101906105B Pyrazolo (1,5-a) pyrimidone derivative as well as drug combination thereof and application thereof |
| 01/16/2013 | CN101878027B Multitarget compounds active at a PPAR and cannabinoid receptor |
| 01/16/2013 | CN101869633B Enteric-coated medicament combination containing epigallocatechin gallate |
| 01/16/2013 | CN101711244B 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| 01/16/2013 | CN101559092B Application of eucommia ulmoides extracts |
| 01/16/2013 | CN101411876B Neurotoxic oligomers |
| 01/15/2013 | US8354448 Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes |
| 01/15/2013 | US8354447 mGLU receptors antagonists for treating disorders associated with mGLU receptors including addiction and depression |
| 01/15/2013 | US8354438 Neurological functions |
| 01/15/2013 | US8354405 6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 01/15/2013 | US8354397 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 01/15/2013 | US8354395 Method for providing neuroprotection from spinal muscular atrophy |
| 01/15/2013 | CA2702834C Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 01/15/2013 | CA2650577C Use of 12-imidazolyl-1-dodecanol or its pharmaceutically acceptable salts for producing a pharmaceutical preparation |
| 01/15/2013 | CA2597016C Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine |
| 01/15/2013 | CA2561873C An alginate oligosaccharide and its derivatives, and the preparation and uses thereof |
| 01/15/2013 | CA2547391C Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 01/15/2013 | CA2524161C Pyridinyl acetonitriles |
| 01/15/2013 | CA2430133C Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 01/15/2013 | CA2406725C Edg8 receptor, its preparation and use |
| 01/10/2013 | WO2013006758A1 Diphosphate mimetics and uses thereof |
| 01/10/2013 | WO2013006400A1 Compounds for the treatment of addiction |
| 01/10/2013 | WO2013006076A1 The use of intranasally administered hsp70 protein to treat neurodegenerative diseases |
| 01/10/2013 | WO2013005798A1 Novel nitrogenated heterocyclic ring derivative |
| 01/10/2013 | WO2013005755A1 Methylpiperidine derivative |
| 01/10/2013 | WO2013005354A1 Heterocyclic compound |
| 01/10/2013 | WO2013005108A1 Egfr targeted therapy |
| 01/10/2013 | WO2013005094A1 Acid addition salt of donepezil and pharmaceutical composition thereof |
| 01/10/2013 | WO2013005017A1 Cannabinoids for use in the treatment of neurodegenerative diseases or disorders |
| 01/10/2013 | WO2013004996A1 5- or 6 - substituted 3 - hydroxy - 2 ( 1h) - pyridinones as d-amino acid oxidase (daao) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain |
| 01/10/2013 | WO2013004995A1 Pyrimidinone compounds and their use |
| 01/10/2013 | WO2013004984A1 Tricyclic compounds for use as kinase inhibitors |
| 01/10/2013 | WO2013004740A1 Anticonvulsant activity of turmeric oil and bisabolene sesquiterpenoids |
| 01/10/2013 | WO2013004642A1 1, 2, 4 -thiadiazol- 5 -ylpiperazine derivatives useful in the treatment neurodegenerative diseases |
| 01/10/2013 | WO2013004617A1 Pyrazolopyridines useful in the treatment of disorders of the central nervous system |
| 01/10/2013 | WO2013004557A1 A molecule regulating activity of insulin degrading enzyme (ide) |